Notably, prior work in a different system (e.g., mesenchymal stem cells overexpressing FoxM1 in an ARDS model) has shown that FoxM1 overexpression can augment tissue repair, offering supportive precedent for such an approach [38]. The gene discussed is FOXM1; the disease is acute respiratory distress syndrome.